Modification Protocol Section News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FDA has recently published two much-anticipated items related to artificial intelligence (“AI”), one pertaining to medical devices and the other to drug manufacturing. FDA has cleared.

Device software functionsEuropean unionSubmission recommendationsPredetermined change control planMachine learningEnabled device software functionsDrug manufacturingImpact assessmentModification protocolModification protocol sectionDrug manufacturersArtificial intelligence act